Pridopidine improves overall mitochondrial function in cellular models of Huntington's disease

被引：0
|
作者：
Naia, L. [1 ]
Maranga, C. [1 ]
Lopes, C. [1 ]
Geva, M. [2 ,3 ]
Hayden, M. [3 ]
Cristina Rego, A. [1 ,4 ]
机构：
[1] Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Teva Pharmaceut Ind, Petah Tiqwa, Israel
[3] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada
[4] Univ Coimbra, Fac Med, Coimbra, Portugal
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
W2-O10
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [1] The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models
    Luana Naia
    Philip Ly
    Sandra I. Mota
    Carla Lopes
    Carina Maranga
    Patrícia Coelho
    Noga Gershoni-Emek
    Maria Ankarcrona
    Michal Geva
    Michael R. Hayden
    A. Cristina Rego
    Neurotherapeutics, 2021, 18 : 1017 - 1038
  • [2] The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models
    Naia, Luana
    Ly, Philip
    Mota, Sandra I.
    Lopes, Carla
    Maranga, Carina
    Coelho, Patricia
    Gershoni-Emek, Noga
    Ankarcrona, Maria
    Geva, Michal
    Hayden, Michael R.
    Rego, A. Cristina
    NEUROTHERAPEUTICS, 2021, 18 (02) : 1017 - 1038
  • [3] Pridopidine for the treatment of Huntington's disease
    Shannon, Kathleen M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (04) : 485 - 492
  • [4] Pridopidine in the treatment of Huntington's disease
    Jablonska, Magdalena
    Grzelakowska, Klaudyna
    Wisniewski, Bartlomiej
    Mazur, Ewelina
    Leis, Kamil
    Galazka, Przemyslaw
    REVIEWS IN THE NEUROSCIENCES, 2020, 31 (04) : 441 - 451
  • [5] The Pridopidine Paradox in Huntington's Disease
    Reilmann, Ralf
    MOVEMENT DISORDERS, 2013, 28 (10) : 1321 - 1324
  • [6] Pridopidine for the Treatment of Early Huntington's Disease
    Geva, M.
    Reilmann, R.
    Olanow, C.
    Leinonen, M.
    Cohen, Y.
    Meyer, P.
    McGarry, A.
    Sabri, O.
    Hayden, M.
    Kieburtz, K.
    MOVEMENT DISORDERS, 2020, 35 : S99 - S99
  • [7] The PROOF-HD Study: Pridopidine's Outcome on Function in Huntington's Disease
    Reilmann, Ralf
    Feigin, Andrew S.
    Geva, Michal
    McGarry, Andrew
    Cohen, Yael
    Gershoni-Emek, Noga
    Mehra, Munish
    Olanow, C. Warren
    Kieburtz, Karl
    Hayden, Michael R.
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 32 - 33
  • [8] HUNTEXIL (PRIDOPIDINE) IMPROVES VOLUNTARY MOTOR FUNCTION IN PATIENTS WITH HUNTINGTON'S DISEASE: RESULTS FROM THE PHASE 3 STUDY MERMAIHD
    Squitieri, F.
    Landwehrmeyer, G. B.
    de Yebenes, J. Garcia
    Reilmann, R.
    Rosser, A.
    Sword, A.
    Rembratt, A.
    Tedroff, J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A49 - A49
  • [9] Pridopidine in treatment of Huntington's disease: beyond chorea?
    Feigin, Andrew
    LANCET NEUROLOGY, 2011, 10 (12): : 1036 - 1037
  • [10] POTENTIAL NEUROPROTECTIVE EFFECTS OF PRIDOPIDINE IN HUNTINGTON'S DISEASE
    Di Pardo, A.
    Alberti, S.
    Maglione, V.
    Amico, E.
    Squitieri, F.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 : A57 - A57
12345